We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Simple Blood Test Could Make It Easier to Diagnose Epilepsy

By LabMedica International staff writers
Posted on 14 Mar 2023

Epilepsy refers to abnormal activity in the brain that results in temporary loss of control of behavior and movement. More...

This condition can be congenital, caused by a tumor, stroke, or brain infection, and produce varying symptoms based on the affected region of the brain. Diagnosing epilepsy can be a challenging and resource-intensive process, and differentiating it from other conditions is often difficult. As such, there exists a pressing need to develop better diagnostic tools, particularly for use early on after a suspected seizure. Now, researchers have discovered higher levels of immune proteins in the blood before and after an epileptic seizure that could serve as possible biomarkers, allowing for accurate diagnosis of epilepsy using a simple blood test.

Researchers from Lund University (Lund, Sweden) began looking for potential biomarkers for epilepsy within the immune system as the inflammation processes that begin as an immune response in the body are also capable of provoking a seizure. The researchers also conducted a comparative analysis of epileptic seizures with psychogenic non-epileptic seizures which is a psychiatric diagnosis that can exhibit clinical symptoms closely resembling those witnessed in epilepsy, thus leading to frequent misdiagnosis. Psychogenic seizure is a chronic disorder that remains underdiagnosed and is usually erroneously treated with epilepsy medication. As such, there is a compelling need for a more straightforward differentiation method between the two conditions.

By analyzing the blood samples of individuals who recently experienced epileptic seizures, researchers identified a significant increase in the levels of five distinct inflammation markers or proteins. Conversely, for individuals experiencing psychogenic seizures, there was no notable variation in the biomarker concentration. This suggests that a simple blood test administered to patients arriving at the emergency room following a seizure could reveal elevated immunological responses, indicating the possibility of an epileptic seizure. In contrast, if these biomarker levels are normal, there is a greater likelihood of a psychogenic seizure, thereby offering an initial indication of how the patient should be evaluated further.

“We call these markers ‘fingerprints’ since they involve several inflammation-related proteins with different reaction patterns,” said Marie Taylor, physician, and doctoral student in the research team. “The patients who had epilepsy showed raised levels of one of the five proteins – IL-6 – even before their seizures, a value that transiently raised even further directly after the seizure.”

“The next stage is to repeat our studies on a broader and less homogenous patient group, where we investigate the ‘fingerprint’ in adults with epilepsy,” added Christine Ekdahl Clementson, group leader, and associate professor at Lund University. “We also want to see whether the biomarkers respond in the same way in children, where the causes of epilepsy are more often genetic.”

Related Links:
Lund University 


Gold Member
Serological Pipets
INTEGRA Serological Pipets
Portable Electronic Pipette
Mini 96
New
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
New
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.